These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32897407)

  • 1. [Data monitoring committees-state of the art and perspectives for the future].
    Fischer T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Dec; 63(12):1511-1518. PubMed ID: 32897407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving effective informed oversight by DMCs in COVID clinical trials.
    DeMets DL; Fleming TR
    J Clin Epidemiol; 2020 Oct; 126():167-171. PubMed ID: 32659363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data Safety Monitoring during Covid-19: Keep On Keeping On.
    Barnbaum DR
    Ethics Hum Res; 2020 May; 42(3):43-44. PubMed ID: 32421950
    [No Abstract]   [Full Text] [Related]  

  • 5. Data monitoring committees for clinical trials evaluating treatments of COVID-19.
    Mütze T; Friede T
    Contemp Clin Trials; 2020 Nov; 98():106154. PubMed ID: 32961361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
    Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
    Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expert committees in German public health policymaking during the SARS-CoV-2 pandemic: a document analysis].
    Sell K; Saringer-Hamiti L; Geffert K; Strahwald B; Stratil JM; Pfadenhauer LM
    Z Evid Fortbild Qual Gesundhwes; 2021 Oct; 165():1-12. PubMed ID: 34474991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis.
    Tan DHS; Agrawal R; Barnabas RV; Giles JT; Dull P
    Trials; 2020 Sep; 21(1):815. PubMed ID: 32993804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SARS coronavirus-2 vaccines: options and state-of-the-art].
    Huckriede ALW
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].
    Otto-Knapp R; Häcker B; Breuer C; Diel R; Kaufmann SHE; Korr G; Pfeiffer M; Schaberg T; Schönfeld N; Witte P; Bauer T
    Pneumologie; 2020 Jul; 74(7):412-416. PubMed ID: 32674189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ethics Committee experience during COVID-19 emergency. A brief report.].
    Bugarín González R; Romero-Yuste SM; López Vázquez PM; Casariego Rosón J; Carballeda Feijóo N; Cruz Del Río JM; Cueva Bañuelos JF; Fernández Rial JÁ; Fernández Trisac JL; Ferreira Díaz MJ; Millán Calenti RÁ; Pía Morandeira A; Prado Casal J; Rodríguez-Tenreiro Sánchez C; Santos García D; Vázquez Lago JM; Verdejo González MA; Zarra Ferro I
    Rev Esp Salud Publica; 2020 Nov; 94():. PubMed ID: 33140740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical guidelines for deliberately infecting volunteers with COVID-19.
    Richards AD
    J Med Ethics; 2020 Aug; 46(8):502-504. PubMed ID: 32461245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, diagnosis, treatment, and future perspectives concerning SARS-COV-2: a review article.
    Carvalho ARVS; Cezarotti Filho ML; Azevedo PCP; Silveira Filho RN; Barbosa FT; Rocha TJM; Sousa-Rodrigues CF; Ramos FWDS
    Rev Assoc Med Bras (1992); 2020 Mar; 66(3):370-374. PubMed ID: 32520160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus drugs trials must get bigger and more collaborative.
    Nature; 2020 May; 581(7807):120. PubMed ID: 32405023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Data monitoring committees. Third pillar in the methodical conduct of clinical trials].
    Fischer T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):793-6. PubMed ID: 18563280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials during COVID-19.
    Singh AG; Chaturvedi P
    Head Neck; 2020 Jul; 42(7):1516-1518. PubMed ID: 32348582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.